Trial
NCT04130282
VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Oxford
Collaborators
—
Condition
Malaria,Falciparum
Intervention
Pfs25-IMX313/Matrix-M1
Why stopped
Delays caused by Covid-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-29